Mirikizumab Antibody
Mirikizumab is a humanized monoclonal antibody that selectively inhibits the p19 subunit of interleukin-23 (IL-23), blocking its receptor interaction. It is utilized in preclinical and clinical research, including in vitro binding assays and in vivo models, for investigating immune-mediated diseases such as ulcerative colitis.
Product Specifications
Product Name Alternative
LY3074828, LY 3074828
Target
Interleukin, IL Receptor
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation
Concentration
3.33 mg/mL
Purity
95.00% (May vary between batches)
Molecular Weight
144.26 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
orb1652562-01 20 µg
Recombinant Silene chalcedonica Ribosome-inactivating protein lychnin
Sign In for Pricing
View Details orb1652562-02 100 µg
Recombinant Silene chalcedonica Ribosome-inactivating protein lychnin
Sign In for Pricing
View Details orb1652562-03 1 mg
Recombinant Silene chalcedonica Ribosome-inactivating protein lychnin
Sign In for Pricing
View Details 
MBS6251982-02 5x 0.1 mL
Luciferase (Luciferin 4-monooxygenase) (PE)
Sign In for Pricing
View Details